Literature DB >> 23423184

Health innovation in cardiovascular diseases.

Su May Liew1, Adina Abdullah, Nurdiana Abdullah, Yook Chin Chia.   

Abstract

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide. Despite efforts to tackle CVD, its prevalence continues to escalate in almost every country. The problem requires an exploration of novel ways to uncover solutions. Health innovations that embrace new knowledge and technology possess the potential to revolutionize the management of CVD. Using findings from published studies on CVD, researchers generated innovations in the areas of global risk assessment, home and remote monitoring and bedside testing. The use of pharmacogenetics and methods to support lifestyle changes represent other potential topics for innovations. Gaps in existing knowledge and practice of CVD provide opportunities for the development of new ideas, practices and technology. However, healthcare professionals need to be cognisant of the limitations of health innovations and advocate for safeguarding patients' wellbeing.

Entities:  

Keywords:  Health innovations; cardiovascular diseases

Year:  2013        PMID: 23423184      PMCID: PMC3575070          DOI: 10.4066/AMJ.2013.1629

Source DB:  PubMed          Journal:  Australas Med J        ISSN: 1836-1935


  6 in total

1.  Effect of smoking relapse on outcome after acute coronary syndromes.

Authors:  Furio Colivicchi; David Mocini; Marco Tubaro; Alessandro Aiello; Piero Clavario; Massimo Santini
Journal:  Am J Cardiol       Date:  2011-07-07       Impact factor: 2.778

2.  ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.

Authors:  Jan M Friedman
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-07-11

3.  Priority actions for the non-communicable disease crisis.

Authors:  Robert Beaglehole; Ruth Bonita; Richard Horton; Cary Adams; George Alleyne; Perviz Asaria; Vanessa Baugh; Henk Bekedam; Nils Billo; Sally Casswell; Michele Cecchini; Ruth Colagiuri; Stephen Colagiuri; Tea Collins; Shah Ebrahim; Michael Engelgau; Gauden Galea; Thomas Gaziano; Robert Geneau; Andy Haines; James Hospedales; Prabhat Jha; Ann Keeling; Stephen Leeder; Paul Lincoln; Martin McKee; Judith Mackay; Roger Magnusson; Rob Moodie; Modi Mwatsama; Sania Nishtar; Bo Norrving; David Patterson; Peter Piot; Johanna Ralston; Manju Rani; K Srinath Reddy; Franco Sassi; Nick Sheron; David Stuckler; Il Suh; Julie Torode; Cherian Varghese; Judith Watt
Journal:  Lancet       Date:  2011-04-05       Impact factor: 79.321

Review 4.  Lipids and coronary heart disease in Asia.

Authors:  K L Khoo; H Tan; Y M Liew; J P Deslypere; E Janus
Journal:  Atherosclerosis       Date:  2003-07       Impact factor: 5.162

Review 5.  Interventions for enhancing medication adherence.

Authors:  R B Haynes; E Ackloo; N Sahota; H P McDonald; X Yao
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

6.  Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.

Authors:  Donald M Lloyd-Jones; Eric P Leip; Martin G Larson; Ralph B D'Agostino; Alexa Beiser; Peter W F Wilson; Philip A Wolf; Daniel Levy
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.